Literature DB >> 11470051

The benefits and limitations of a physical training program in patients with inflammatory myositis.

M Lawson Mahowald1.   

Abstract

The clinical features of inflammatory myositis are determined by the severity and extent of muscle weakness and systemic manifestations. The benefits and limitations of physical training programs and rehabilitation strategies depend on the clinical phase of the disease and analysis of underlying impairments responsible for functional limitations in the patient. Patients with early stage disease and severe weakness will be treated differently than patients who have responded to medication and are improving. Not all patients will respond to medications; their therapy programs will have different requirements. This article reviews available data on the physiologic responses to exercise in patients with inflammatory muscle diseases. New data support more aggressive approaches to progressive strengthening exercises for patients with inflammatory myositis.

Entities:  

Mesh:

Year:  2001        PMID: 11470051     DOI: 10.1007/s11926-001-0036-z

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  36 in total

1.  Inclusion body myositis: analysis of 32 cases.

Authors:  M E Sayers; S M Chou; L H Calabrese
Journal:  J Rheumatol       Date:  1992-09       Impact factor: 4.666

2.  Inclusion body myositis with cricopharyngeus muscle involvement and severe dysphagia.

Authors:  A Verma; W G Bradley; A M Adesina; R Sofferman; W W Pendlebury
Journal:  Muscle Nerve       Date:  1991-05       Impact factor: 3.217

3.  Experimental human muscle damage: morphological changes in relation to other indices of damage.

Authors:  D A Jones; D J Newham; J M Round; S E Tolfree
Journal:  J Physiol       Date:  1986-06       Impact factor: 5.182

Review 4.  Evaluation and treatment of speech and swallowing disorders associated with myopathies.

Authors:  B C Sonies
Journal:  Curr Opin Rheumatol       Date:  1997-11       Impact factor: 5.006

Review 5.  Inclusion body myositis.

Authors:  L H Calabrese; S M Chou
Journal:  Rheum Dis Clin North Am       Date:  1994-11       Impact factor: 2.670

6.  Swallowing disorders in muscular diseases: functional assessment and indications of cricopharyngeal myotomy.

Authors:  J L St Guily; S Périé; T N Willig; S Chaussade; B Eymard; B Angelard
Journal:  Ear Nose Throat J       Date:  1994-01       Impact factor: 1.697

7.  Resistive exercise in the rehabilitation of polymyositis/dermatomyositis.

Authors:  A Escalante; L Miller; T D Beardmore
Journal:  J Rheumatol       Date:  1993-08       Impact factor: 4.666

8.  Acute phase response in exercise. III. Neutrophil and IL-1 beta accumulation in skeletal muscle.

Authors:  R A Fielding; T J Manfredi; W Ding; M A Fiatarone; W J Evans; J G Cannon
Journal:  Am J Physiol       Date:  1993-07

Review 9.  Evaluation of neuromuscular function in inflammatory myopathy.

Authors:  R T Moxley
Journal:  Rheum Dis Clin North Am       Date:  1994-11       Impact factor: 2.670

10.  Exercise limitation in patients with polymyositis.

Authors:  C A Hebert; T J Byrnes; B A Baethge; R E Wolf; G T Kinasewitz
Journal:  Chest       Date:  1990-08       Impact factor: 9.410

View more
  3 in total

Review 1.  Foot tendinopathies in rheumatic diseases: etiopathogenesis, clinical manifestations and therapeutic options.

Authors:  A Frizziero; V Bonsangue; M Trevisan; P R J Ames; S Masiero
Journal:  Clin Rheumatol       Date:  2012-12-30       Impact factor: 2.980

Review 2.  Idiopathic inflammatory myopathies: a treatment update.

Authors:  Chester V Oddis
Journal:  Curr Rheumatol Rep       Date:  2003-12       Impact factor: 4.592

3.  Exercise immunology: the current state of man and mouse.

Authors:  Christer Malm
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.